Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway. [electronic resource]
Producer: 20170303Description: 342-8 p. digitalISSN:- 1791-2431
- Apoptosis -- drug effects
- Breast Neoplasms -- drug therapy
- Caspase 3 -- metabolism
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclin D1 -- metabolism
- Female
- Flavonoids -- pharmacology
- Gene Expression Regulation, Neoplastic -- drug effects
- Glycogen Synthase Kinase 3 -- metabolism
- Humans
- Inhibitor of Apoptosis Proteins -- metabolism
- MAP Kinase Signaling System -- drug effects
- MCF-7 Cells
- Mitogen-Activated Protein Kinases -- metabolism
- Proliferating Cell Nuclear Antigen -- metabolism
- Signal Transduction -- drug effects
- Survivin
- bcl-2-Associated X Protein -- metabolism
- beta Catenin -- metabolism
- p21-Activated Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.